Study of assessment of susceptibility with focus on respiratory tract infection in age group of 18 years to 40 years.

Phase 3

Not yet recruiting

Brief Summary: There is a general misconception that homoeopathy as a medical science is more efficacious in chronic diseases than in acute diseases. Contrary to this misconception homoeopathy also has a better scope in acute diseases, as the susceptibility is very prominent, sensitivity is high and the reactivity is quick. Hence, to medicine in acute disease is becoming more susceptibility. Homoeopathy being an effective system of medicine deals with any disease condition in a holistic way and caters to the needs of the present scenario and possesses a better scope for the treatment of Respiratory tract infection. A proper understanding of the dynamic concept of disease of susceptibility and of remedy is essential grasp of the most important aspect of homoeopathic practice. The ever changing kaleidoscopic picture presented by homoeopathic posology consists of well with the firm application of the law of similar and the concept of susceptibility.

Recruitment & Eligibility

Inclusion Criteria

1. Various socioeconomic groups will be included. 2. Patients of 18.
40 years of age groups who fulfilled the standard case definition. 3. Patients of both sexes will be included in the study. 4. Patient without any other systemic diseases. 5. Patient giving written consent form.

Exclusion Criteria

That doesnâ€˜t fulfil the diagnostic criteria.
Patients of regular medical care for any other chronic conditions like congenital malformation of respiratory tract, specific lungs disease.
Patients undertaking immune suppressive therapy will be excluded.
Patients with Psychiatric diagnosis.
Recent major surgery.
Patients requiring emergency medical care.
Patients who have participated in any other Research study in the last 6 months.
Those under other medications.
Or using any other medicine during the study period.
Pregnant and lactating women.
Patient who are not written the consent form.

Primary Outcome Measures

Name	Time	Method
1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21	1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again \| after every 15 days, for the total of 3 months. \| 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.
before and after the treatment.	1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again \| after every 15 days, for the total of 3 months. \| 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.
2. To investigate the utility and efficacy of homoeopathic medicine for the	1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again \| after every 15 days, for the total of 3 months. \| 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.
treatment of acute and recurrent URTIs.	1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again \| after every 15 days, for the total of 3 months. \| 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.

Secondary Outcome Measures

Name	Time	Method
To observe the changes in quality of life of patient with acute and recurrent URTIs after taking treatment.	Assessment on day 1 and after 3 months.

Locations (1): Bharati Vidyapeeth Homoeopathic Medical College and Hospital Pune
🇮🇳
Pune, MAHARASHTRA, India
Bharati Vidyapeeth Homoeopathic Medical College and Hospital Pune
🇮🇳Pune, MAHARASHTRA, India
Dr Moiranhthem Krishnakumari Devi
Principal investigator
8073914709
kkmoirangthem18@gmail.com